BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 27072986)

  • 21. Alterations of p53, cyclin D1 and pRB expression in the carcinogenesis of esophageal squamous cell carcinoma.
    Kawakubo H; Ozawa S; Ando N; Kitagawa Y; Mukai M; Ueda M; Kitajima M
    Oncol Rep; 2005 Dec; 14(6):1453-9. PubMed ID: 16273238
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A cancer-array approach elucidates the immune escape mechanism and defects in the DNA repair system in esophageal squamous cell carcinoma.
    Dadkhah E; Naseh H; Farshchian M; Memar B; Sankian M; Bagheri R; Forghanifard MM; Montazer M; Kazemi Noughabi M; Hashemi M; Abbaszadegan MR
    Arch Iran Med; 2013 Aug; 16(8):463-70. PubMed ID: 23906251
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decreased Tumor Suppressor Candidate 3 Predicts Poor Prognosis of Patients with Esophageal Squamous Cell Carcinoma.
    Yu X; Zhang J; Zhong H; Liu F; Liang N; Wang Y; Meng X; Du J
    Int J Med Sci; 2016; 13(12):963-969. PubMed ID: 27994502
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overexpression of ATPase Na+/+ transporting alpha 1 polypeptide, ATP1A1, correlates with clinical diagnosis and progression of esophageal squamous cell carcinoma.
    Wu IC; Chen YK; Wu CC; Cheng YJ; Chen WC; Ko HJ; Liu YP; Chai CY; Lin HS; Wu DC; Wu MT
    Oncotarget; 2016 Dec; 7(51):85244-85258. PubMed ID: 27845894
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Profiling of differentially expressed cancer-related genes in esophageal squamous cell carcinoma (ESCC) using human cancer cDNA arrays: overexpression of oncogene MET correlates with tumor differentiation in ESCC.
    Hu YC; Lam KY; Law S; Wong J; Srivastava G
    Clin Cancer Res; 2001 Nov; 7(11):3519-25. PubMed ID: 11705871
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A variable structure fuzzy neural network model of squamous dysplasia and esophageal squamous cell carcinoma based on a global chaotic optimization algorithm.
    Moghtadaei M; Hashemi Golpayegani MR; Malekzadeh R
    J Theor Biol; 2013 Feb; 318():164-72. PubMed ID: 23174279
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autoantibody detection to tumor-associated antigens of P53, IMP1, P16, cyclin B1, P62, C-myc, Survivn, and Koc for the screening of high-risk subjects and early detection of esophageal squamous cell carcinoma.
    Zhou SL; Yue WB; Fan ZM; Du F; Liu BC; Li B; Han XN; Ku JW; Zhao XK; Zhang P; Cui J; Zhou FY; Zhang LQ; Fan XP; Zhou YF; Zhu LL; Liu HY; Wang LD
    Dis Esophagus; 2014; 27(8):790-7. PubMed ID: 24147952
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of esophageal squamous cell carcinoma by cathepsin B activity in nude mice.
    Ma W; Ma L; Zhe H; Bao C; Wang N; Yang S; Wang K; Cao F; Cheng Y; Cheng Y
    PLoS One; 2014; 9(3):e92351. PubMed ID: 24618814
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytological screening and 15 years' follow-up (1986-2001) for early esophageal squamous cell carcinoma and precancerous lesions in a high-risk population in Anyang County, Henan Province, Northern China.
    Wang LD; Yang HH; Fan ZM; Lü XD; Wang JK; Liu XL; Sun Z; Jiang YN; He X; Zhou Q
    Cancer Detect Prev; 2005; 29(4):317-22. PubMed ID: 16118042
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel serum microRNA signature to screen esophageal squamous cell carcinoma.
    Huang Z; Zhang L; Zhu D; Shan X; Zhou X; Qi LW; Wu L; Zhu J; Cheng W; Zhang H; Chen Y; Zhu W; Wang T; Liu P
    Cancer Med; 2017 Jan; 6(1):109-119. PubMed ID: 28035762
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elevated maspin expression is associated with better overall survival in esophageal squamous cell carcinoma (ESCC).
    Wang Y; Sheng S; Zhang J; Dzinic S; Li S; Fang F; Wu N; Zheng Q; Yang Y
    PLoS One; 2013; 8(5):e63581. PubMed ID: 23717449
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endoscopic Surveillance for Premalignant Esophageal Lesions: A Community-Based Multicenter, Prospective Cohort Study.
    Li H; Zhang S; Zhou J; Tong F; Gong J; Zha Z; Li N; Xia C; Li J; Zheng L; Luo P; Han R; Ma H; Lv Y; Zeng H; Zheng R; Cao M; Yang F; Yan X; Sun D; He S; Zhang S; Chen W; He J
    Clin Gastroenterol Hepatol; 2023 Mar; 21(3):653-662.e8. PubMed ID: 35623589
    [TBL] [Abstract][Full Text] [Related]  

  • 33. USP9X expression correlates with tumor progression and poor prognosis in esophageal squamous cell carcinoma.
    Peng J; Hu Q; Liu W; He X; Cui L; Chen X; Yang M; Liu H; Wei W; Liu S; Wang H
    Diagn Pathol; 2013 Oct; 8():177. PubMed ID: 24152793
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bioinformatics identification of lncRNA biomarkers associated with the progression of esophageal squamous cell carcinoma.
    Yu J; Wu X; Huang K; Zhu M; Zhang X; Zhang Y; Chen S; Xu X; Zhang Q
    Mol Med Rep; 2019 Jun; 19(6):5309-5320. PubMed ID: 31059058
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of a DNA methylome profile of esophageal squamous cell carcinoma and potential plasma epigenetic biomarkers for early diagnosis.
    Li X; Zhou F; Jiang C; Wang Y; Lu Y; Yang F; Wang N; Yang H; Zheng Y; Zhang J
    PLoS One; 2014; 9(7):e103162. PubMed ID: 25050929
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MN antigen expression in normal, preneoplastic, and neoplastic esophagus: a clinicopathological study of a new cancer-associated biomarker.
    Turner JR; Odze RD; Crum CP; Resnick MB
    Hum Pathol; 1997 Jun; 28(6):740-4. PubMed ID: 9191010
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endoscopic screening for esophageal squamous-cell carcinoma in high-risk patients: a prospective study conducted in 62 French endoscopy centers.
    Dubuc J; Legoux J-; Winnock M; Seyrig J-; Barbier J-; Barrioz T; Laugier R; Boulay G; Grasset D; Sautereau D; Grigoresco D; Butel J; Scoazec J-; Ponchon T;
    Endoscopy; 2006 Jul; 38(7):690-5. PubMed ID: 16874909
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TNFAIP3 overexpression is an independent factor for poor survival in esophageal squamous cell carcinoma.
    Hadisaputri YE; Miyazaki T; Yokobori T; Sohda M; Sakai M; Ozawa D; Hara K; Honjo H; Kumakura Y; Kuwano H
    Int J Oncol; 2017 Mar; 50(3):1002-1010. PubMed ID: 28197630
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High expression of TACC3 in esophageal squamous cell carcinoma correlates with poor prognosis.
    Huang ZL; Lin ZR; Xiao YR; Cao X; Zhu LC; Zeng MS; Zhong Q; Wen ZS
    Oncotarget; 2015 Mar; 6(9):6850-61. PubMed ID: 25760075
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ADH1B and ALDH2 are associated with metachronous SCC after endoscopic submucosal dissection of esophageal squamous cell carcinoma.
    Kagemoto K; Urabe Y; Miwata T; Oka S; Ochi H; Kitadai Y; Tanaka S; Chayama K
    Cancer Med; 2016 Jul; 5(7):1397-404. PubMed ID: 27038040
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.